FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313482964> ?p ?o ?g. }

• W4313482964 endingPage "245" @default.
• W4313482964 startingPage "245" @default.
• W4313482964 abstract "Importance Excessive bleeding requiring fibrinogen replacement is a serious complication of cardiac surgery. However, the relative cost-effectiveness of the 2 available therapies—fibrinogen concentrate and cryoprecipitate—is unknown. Objective To determine cost-effectiveness of fibrinogen concentrate vs cryoprecipitate for managing active bleeding in adult patients who underwent cardiac surgery. Design, Setting, and Participants A within-trial economic evaluation of the Fibrinogen Replenishment in Surgery (FIBERS) randomized clinical trial (February 2017 to November 2018) that took place at 4 hospitals based in Ontario, Canada, hospitals examined all in-hospital resource utilization costs and allogeneic blood product (ABP) transfusion costs incurred within 28 days of surgery. Participants included a subset of 495 adult patients from the FIBERS trial who underwent cardiac surgery and developed active bleeding and acquired hypofibrinogenemia requiring fibrinogen replacement. Interventions Fibrinogen concentrate (4 g per dose) or cryoprecipitate (10 units per dose) randomized (1:1) up to 24 hours postcardiopulmonary bypass. Main Outcomes and Measures Effectiveness outcomes included number of ABPs administered within 24 hours and 7 days of cardiopulmonary bypass. ABP transfusion (7-day) and in-hospital resource utilization (28-day) costs were evaluated and a multivariable net benefit regression model built for the full sample and predefined subgroups. Results Patient level costs for 495 patients were evaluated (mean [SD] age 59.2 [15.4] years and 69.3% male.) Consistent with FIBERS, ABP transfusions and adverse events were similar in both treatment groups. Median (IQR) total 7-day ABP cost was CAD $2280 (US dollars [USD] $1697) (CAD $930 [USD $692]-CAD $4970 [USD $3701]) in the fibrinogen concentrate group and CAD $2770 (USD $1690) (IQR, CAD $1140 [USD $849]-CAD $5000 [USD $3723]) in the cryoprecipitate group. Median (interquartile range) total 28-day cost was CAD $38 180 (USD $28 431) $(IQR, CAD $26 350 [USD $19 622]-CAD $65 080 [USD $48 463]) in the fibrinogen concentrate group and CAD $38 790 (USD $28 886) (IQR, CAD $26 180 [USD $19 495]-CAD $70 380 [USD $52 409]) in the cryoprecipitate group. After exclusion of patients who were critically ill before surgery (11%) due to substantial variability in costs, the incremental net benefit of fibrinogen concentrate vs cryoprecipitate was positive (probability of being cost-effective 86% and 97% at $0 and CAD $2000 (USD $1489) willingness-to-pay, respectively). Net benefit was highly uncertain for nonelective and patients with critical illness. Conclusions and Relevance Fibrinogen concentrate is cost-effective when compared with cryoprecipitate in most bleeding adult patients who underwent cardiac surgery with acquired hypofibrinogenemia requiring fibrinogen replacement. The generalizability of these findings outside the Canadian health system needs to be verified." @default.
• W4313482964 created "2023-01-06" @default.
• W4313482964 creator A5008794902 @default.
• W4313482964 creator A5015950115 @default.
• W4313482964 creator A5018575879 @default.
• W4313482964 creator A5068330765 @default.
• W4313482964 creator A5077960444 @default.
• W4313482964 creator A5085988392 @default.
• W4313482964 creator A5090644631 @default.
• W4313482964 creator A5091907592 @default.
• W4313482964 date "2023-03-01" @default.
• W4313482964 modified "2023-09-28" @default.
• W4313482964 title "Cost-effectiveness of Fibrinogen Concentrate vs Cryoprecipitate for Treating Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients" @default.
• W4313482964 cites W1937705451 @default.
• W4313482964 cites W1964496447 @default.
• W4313482964 cites W2013204694 @default.
• W4313482964 cites W2058056848 @default.
• W4313482964 cites W2072289196 @default.
• W4313482964 cites W2111374185 @default.
• W4313482964 cites W2758056441 @default.
• W4313482964 cites W2795201402 @default.
• W4313482964 cites W2795744725 @default.
• W4313482964 cites W2980819145 @default.
• W4313482964 cites W3152345913 @default.
• W4313482964 cites W4211237975 @default.
• W4313482964 cites W4230859011 @default.
• W4313482964 cites W4234024582 @default.
• W4313482964 cites W4238705404 @default.
• W4313482964 cites W4240640476 @default.
• W4313482964 cites W4248767712 @default.
• W4313482964 cites W4252452500 @default.
• W4313482964 doi "https://doi.org/10.1001/jamasurg.2022.6818" @default.
• W4313482964 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36598773" @default.
• W4313482964 hasPublicationYear "2023" @default.
• W4313482964 type Work @default.
• W4313482964 citedByCount "1" @default.
• W4313482964 countsByYear W43134829642023 @default.
• W4313482964 crossrefType "journal-article" @default.
• W4313482964 hasAuthorship W4313482964A5008794902 @default.
• W4313482964 hasAuthorship W4313482964A5015950115 @default.
• W4313482964 hasAuthorship W4313482964A5018575879 @default.
• W4313482964 hasAuthorship W4313482964A5068330765 @default.
• W4313482964 hasAuthorship W4313482964A5077960444 @default.
• W4313482964 hasAuthorship W4313482964A5085988392 @default.
• W4313482964 hasAuthorship W4313482964A5090644631 @default.
• W4313482964 hasAuthorship W4313482964A5091907592 @default.
• W4313482964 hasBestOaLocation W43134829641 @default.
• W4313482964 hasConcept C126322002 @default.
• W4313482964 hasConcept C141071460 @default.
• W4313482964 hasConcept C168563851 @default.
• W4313482964 hasConcept C2777396833 @default.
• W4313482964 hasConcept C2778258694 @default.
• W4313482964 hasConcept C2778789114 @default.
• W4313482964 hasConcept C2778881276 @default.
• W4313482964 hasConcept C2779036427 @default.
• W4313482964 hasConcept C2780014101 @default.
• W4313482964 hasConcept C2910129229 @default.
• W4313482964 hasConcept C71924100 @default.
• W4313482964 hasConceptScore W4313482964C126322002 @default.
• W4313482964 hasConceptScore W4313482964C141071460 @default.
• W4313482964 hasConceptScore W4313482964C168563851 @default.
• W4313482964 hasConceptScore W4313482964C2777396833 @default.
• W4313482964 hasConceptScore W4313482964C2778258694 @default.
• W4313482964 hasConceptScore W4313482964C2778789114 @default.
• W4313482964 hasConceptScore W4313482964C2778881276 @default.
• W4313482964 hasConceptScore W4313482964C2779036427 @default.
• W4313482964 hasConceptScore W4313482964C2780014101 @default.
• W4313482964 hasConceptScore W4313482964C2910129229 @default.
• W4313482964 hasConceptScore W4313482964C71924100 @default.
• W4313482964 hasIssue "3" @default.
• W4313482964 hasLocation W43134829641 @default.
• W4313482964 hasLocation W43134829642 @default.
• W4313482964 hasLocation W43134829643 @default.
• W4313482964 hasOpenAccess W4313482964 @default.
• W4313482964 hasPrimaryLocation W43134829641 @default.
• W4313482964 hasRelatedWork W1837030616 @default.
• W4313482964 hasRelatedWork W2134537379 @default.
• W4313482964 hasRelatedWork W2408782384 @default.
• W4313482964 hasRelatedWork W2904163679 @default.
• W4313482964 hasRelatedWork W294807623 @default.
• W4313482964 hasRelatedWork W3032885167 @default.
• W4313482964 hasRelatedWork W3166807550 @default.
• W4313482964 hasRelatedWork W3169430539 @default.
• W4313482964 hasRelatedWork W4283660947 @default.
• W4313482964 hasRelatedWork W4311450203 @default.
• W4313482964 hasVolume "158" @default.
• W4313482964 isParatext "false" @default.
• W4313482964 isRetracted "false" @default.
• W4313482964 workType "article" @default.